MDL 29,913

MDL 29,913 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

MDL 29913 acts as a NK2 tachykinin receptor selective antagonist used in the treatment of IBS.

MDL 29,913 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

MDL 29,913 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	+16314854226	inquiry@bocsci.com	United States	19743	58
3B Pharmachem (Wuhan) International Co.,Ltd.	821-50328103-801 18930552037	3bsc@sina.com	China	15848	69
Creative Peptides		info@creative-peptides.com	United States	6084	56
Nanjing Leon Biological Technology Co., Ltd.	17705183659	sales@njleonbiotech.com	China	5503	55
BOC Sciences	--	info@bocsci.com	USA	0	65
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	44843	58
Beijing Jin Ming Biotechnology Co., Ltd.	010-60605840	psaitong@jm-bio.com	China	29778	58
Nantong QuanYi Biotechnology Co., Ltd	0513-66337626 18051384581	sales@chemhifuture.com	China	4191	58
RD International Technology Co., Limited	18024082417	market@ubiochem.com	China	9180	58
United States Biological	--	sales@advtechind.com	United States	6106	58

135721-56-1()Verwandte Suche:

---

• M.W. 744.93 C40H56N8O6
• MDL 29,913
• Glycine, N-(2-amino-4-methylpentyl)-N-methyl-L-leucyl-L-glutaminyl-L-tryptophyl-L-phenylalanyl-, (5→1)-lactam (9CI)
• 135721-56-1
• C40H56N8O6
• Tachykinin receptor